Literature DB >> 27536706

IL-33 Signaling in Lung Injury.

Jing Chang1,2, Yue-Feng Xia3,2, Ma-Zhong Zhang1, Li-Ming Zhang2.   

Abstract

Interleukin (IL)-33, a member of the IL-1 cytokine super-family, acts as both a traditional cytokine and an intracellular nuclear factor. It is generally released from damaged immune cells and signals through its receptor ST2 in an autocrine and paracrine fashion, plays important roles in type-2 innate immunity, and functions as an "alarmin" or a danger signal for cellular damage or cellular stress. Here, we review recent advances of the role of IL-33 in lung injury and explore its potential significance as an attractive therapeutic target.

Entities:  

Keywords:  interleukin-33 (IL-33); lung injury; ventilator-induced lung injury (VILI)

Year:  2016        PMID： 27536706      PMCID： PMC4985245     

Source DB:  PubMed          Journal:  Transl Perioper Pain Med


  75 in total

1.  IL-33 mediates inflammatory responses in human lung tissue cells.

Authors:  Akiko Yagami; Kanami Orihara; Hideaki Morita; Kyoko Futamura; Noriko Hashimoto; Kenji Matsumoto; Hirohisa Saito; Akio Matsuda
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.

Authors:  Precious G Motshwene; Martin C Moncrieffe; J Günter Grossmann; Cheng Kao; Murali Ayaluru; Alan M Sandercock; Carol V Robinson; Eicke Latz; Nicholas J Gay
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

4.  Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain.

Authors:  Mélanie Pichery; Emilie Mirey; Pascale Mercier; Emma Lefrancais; Arnaud Dujardin; Nathalie Ortega; Jean-Philippe Girard
Journal:  J Immunol       Date:  2012-02-27       Impact factor: 5.422

5.  The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.

Authors:  Gaby Palmer; Brian P Lipsky; Molly D Smithgall; David Meininger; Sophia Siu; Dominique Talabot-Ayer; Cem Gabay; Dirk E Smith
Journal:  Cytokine       Date:  2008-05-02       Impact factor: 3.861

Review 6.  Acute lung injury and the acute respiratory distress syndrome: a clinical review.

Authors:  Arthur P Wheeler; Gordon R Bernard
Journal:  Lancet       Date:  2007-05-05       Impact factor: 79.321

7.  IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.

Authors:  Shafaqat Ali; Michael Huber; Christian Kollewe; Stephan C Bischoff; Werner Falk; Michael U Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

8.  ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice.

Authors:  Daniela Paclik; Christina Stehle; Annette Lahmann; Andreas Hutloff; Chiara Romagnani
Journal:  Eur J Immunol       Date:  2015-08-31       Impact factor: 5.532

9.  Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33.

Authors:  Paul E Pfeffer; Yin-Huai Chen; Grzegorz Woszczek; Nick C Matthews; Elfy Chevretton; Atul Gupta; Sejal Saglani; Andrew Bush; Chris Corrigan; David J Cousins; Catherine M Hawrylowicz
Journal:  J Allergy Clin Immunol       Date:  2014-11-12       Impact factor: 10.793

10.  A potential role for interleukin-33 and γ-epithelium sodium channel in the pathogenesis of human malaria associated lung injury.

Authors:  Sumate Ampawong; Urai Chaisri; Parnpen Viriyavejakul; Panote Prapansilp; Georges E Grau; Gareth D H Turner; Emsri Pongponratn
Journal:  Malar J       Date:  2015-10-05       Impact factor: 2.979
View more
  3 in total

1.  Type 2 innate lymphoid cells participate in IL-33-stimulated Th2-associated immune response in chronic obstructive pulmonary disease.

Authors:  Min Jiang; Simin Tao; Shaohua Zhang; Jing Wang; Fengbo Zhang; Fengsen Li; Jianbing Ding
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

2.  Pleural Effusion IL-33/sST2 Levels and Effects of Low and High IL-33/sST2 Levels on Human Mesothelial Cell Adhesion and Migration.

Authors:  Ourania S Kotsiou; Rajesh M Jagirdar; Eleftherios D Papazoglou; Chrissi Hatzoglou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Inflammation       Date:  2019-12       Impact factor: 4.657

3.  Cyclic stretch induced IL-33 production through HMGB1/TLR-4 signaling pathway in murine respiratory epithelial cells.

Authors:  Jing Chang; Yuefeng Xia; Karla Wasserloos; Meihong Deng; Kory J Blose; David A Vorp; Heth R Turnquist; Timothy R Billiar; Bruce A Pitt; Ma-Zhong Zhang; Li-Ming Zhang
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.